In our previous study (16), we reported that GLP-1 treatment increased the proliferation as well as the migration of the insulinoma cell line MIN6, and numerous studies have associated GLP-1-based therapies with pancreatic disease in recent years (714,17)
This study is the first to examine the potential cardiovascular benefits of these drugs in a high-risk population of patients with both obesity and an autoimmune diseaseboth of which are associated with a higher risk of cardiovascular and blood clot events
Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal food, Drug, and Coametic Act: Guidance for Industry
Fras JP, Guja C, Hardy E, Ahmed A, Dong F, hman P, et al
Snacking may decrease